elıxdata
Dispositivos MédicosCancelado

ANTICORPOS PARA DETECÇÃO DE CARCINOMAS EM GERAL

10064010097

Registro cancelado em 30/09/2018 segundo a ANVISA.

Informações Gerais

Nome do produto

ANTICORPOS PARA DETECÇÃO DE CARCINOMAS EM GERAL

Número de registro

10064010097

Nome técnico

IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS EM GERAL

Classe de risco

III

Processo

25351337604201094

Empresa Detentora

Razão social

EH BRASIL INDUSTRIA E COMERCIO LTDA.

CNPJ

84.683.556/0001-10

Fabricante

LEICA BIOSYSTEMS NEWCASTLE LTD

País de fabricação

REINO UNIDO

Registro

Situação

Cancelado

Vencimento

Vencido há 291 dias10/01/2026
Histórico de Situação

Nenhuma mudança de situação registrada.

Apresentações / Modelos(99)

  • Ki67

    MM1-L-CE: 1 x 1 ml de NCL-L-Ki67-MM1

  • 5D3-L-CE: 1 X 1 ml de NCL-L-5D3

  • AE1/AE3-L-CE: 1 x 1 ml de NCL-L-AE1/AE3

  • AKT-PHOS-L-CE: 1 x 1 ml de NCL-L-Akt-Phos

  • CA125-L-CE: 1 x 1 ml NCL-L-CA125

  • CALRET566-L-CE: 1 x 1 ml de NCL-L-CALRET-566

  • CB11-L-CE: 1 x 1 ml de NCL-L-CB11

  • CD163-L-CE: 1 x 1 ml de NCL-L-CD163

  • CD56-504-L-CE-H: 1 x 0,5 ml de NCL-L-CD56-504

  • CD56-504-L-CE: 1 x 1 ml de NCL-L-CD56-504

  • CD99-187-L-CE: 1 X 1 ml de NCL-L-CD99-187

  • CK20-561-L-CE: 1 x 1 ml NCL-L-CK20-561

  • CK20-L-CE-H: 1 x 0,5 ml de NCL-L-CK20

  • CK20-L-CE: 1 x 1 ml de NCL-L-CK20

  • CK5-L-CE-H: 1 x 0,5 ml de NCL-L-CK5

  • CK5-L-CE: 1 x 1,0 ml de NCL-L-CK5

  • CK7-560-L-CE: 1 x 1 ml de NCL-L-CK7-560

  • CK7-OVTL-L-CE: 1 x 1 ml de NCL-L-CK7-OVTL

  • E-CAD-L-CE: 1 x 1 ml NCL-L-E-Cad

  • EGFR-L-CE: 1 x 1,0 ml de NCL-L-EGFR

  • EMA-L-CE: 1 x 1 ml de NCL-L-EMA

  • EZH2-L-CE: 1 x 1 ml de NCL-L-EZH2

  • FRALPHA-L-CE: 1 x 1 ml de NCL-L-Fralpha

  • GCDFP15-L-CE: 1 x 1 ml de NCL-L-GCDFP15

  • Geminin-L-CE: 1 x 1 ml de NCL-L-Geminin

  • Inhibina-L-CE: 1 x 1 ml de NCL-L-InhibinA

  • KAP-581-L-CE: 1 x 1 ml de NCL-L-KAP-581

  • LAM-578-L-CE: 1 x 1 ml NCL-L-LAM-578

  • LL002-L-CE-H: 1 x 0,5 ml de NCL-L-LL002

  • LL002-L-CE: 1 x 1 ml de NCL-L-LL002

  • MCM2-597-L-CE: 1 x 00.25 ml de NCL-L-MCM2-597

  • MESO-L-CE: 1 x 1 ml de NCL-L-MESO

  • MLH1-L-CE: 1 x 1 mL de NCL-L-MLH1

  • MSA-594-L-CE: 1 x 1 ml de NCL-L-MSA-594

  • MSH6-L-CE: 1 x 1 ml de NCL-L-MSH6

  • N-CAD-L-CE: 1 x 1 ml de NCL-L-N-Cad

  • Napsina-L-CE: 1 x 1 ml de NCL-L-NapsinA

  • P53-DO7-L-CE-H: 1 x 0,5 ml de NCL-L-p53-DO7

  • P53-DO7-L-CE: 1 x 1 ml de NCL-L-p53-DO7

  • P63-L-CE: 1 x 1 ml de NCL-L-p63

  • PA0014: 1 x 7 ml de HCG Bond RTU Primary

  • PA0022: 1 x 7 ml CK20 Bond RTU primary

  • PA0033: 1 x 7 ml de Vimentin Bond RTU primary

  • PA0035: 1 x 7 ml de E3MA Bond RTU Primary

  • PA0037: 1 x 30 ml CK20 Bond RTU primary

  • PA0057: 1 x 7 ml de p53 Bond RTU Primary

  • PA0067: 1 x 7 ml de CK8/18 Bond RTU primary

  • PA0074: 1 x 7 ml de Cytokeratin 14 Bond RTU primary

  • PA0083: 1 x 7 ml de Beta Catenin Bond RTU Primary

  • PA0090: 1 x 7 ml de CD163 Bond RTU Primary

  • PA0103: 1 x 7 ml p63 Bond RTU primary

  • PA0114: 1 x 7 ml de Cytokeratin 17 Bond RTU primary

  • PA0118: 1 x 7 ml de Ki67 Bond RTU Primary

  • PA0134: 1 x 7 ml CK HMW Bond RTU primary

  • PA0138: 1 x 30 ml de Cytokeratin 7 Bond RTU primary

  • PA0191: 1 x 7 ml de CD56 Bond RTU Primary

  • PA0230: 1 x 7 ml de Ki67 (K2) Bond RTU Primary

  • PA0238: 1 x 7 ml Galectin-3 Bond RTU Primary

  • PA0250: 1 x 7 ml CD31 Bond RTU Primary

  • PA0305: 1 x 7 ml CD25 Bond RTU Primary

  • PA0308: 1 x 7 ml de CD61 Bond RTU Primary

  • PA0346: 1 x 7 ml de Calretinin Bond RTU Primary

  • PA0373: 1 x 7 ml de Mesothelin Bond RTU primary

  • PA0387: 1 x 7 mL E-Cadherin Bond RTU primary

  • PA0400: 1 x 7 ml VWF Bond RTU Primary

  • PA0410: 1 x 30 ml de Ki67 Bond RTU Primary

  • PA0416: 1 x 7 ml Calponin B Bond RTU Primary

  • PA0424: 1 x 7 ml CA19-9 Bond RTU Primary

  • PA0443: 1 x 7 ml CD57 Bond RTU Primary

  • PA0449: 1 x 7 ml Factor XIIIa Bond RTU Primary

  • PA0468: 1 x 7 ml de Cytokeratin 5 Bond RTU Primary

  • PA0509: 1 x 7 ml de CD99 Bond RTU Primary

  • PA0539: 1 x 7 ml de CA125 Bond RTU Primary

  • PA0562: 1 x 7 ml de Wilms Tumor Bond RTU Primary

  • PA0567: 1 x 7 ml Cytokeratin 8 Bond RTU Primary

  • PA0570: 1 x 7 ml de Lambda Light Chain Bond RTU Primary

  • PA0606: 1 x 7 ml Kappa Light Chain Bond RTU Primary

  • PA0610: 1 x 7 ml de MLH1 Bond RTU Primary

  • PA0620: 1 x 7 ml Insulin Bond RTU Primary

  • PA0640: 1 x 7 ml de Vimentin Bond RTU primary

  • PA0681: 1 x 7 ml Gastrin Bond RTU Primary

  • PA0693: 1 x 7 ml de HFSH Bond RTU Primary

  • PA0704: 1 x 7 ml de HGH Bond RTU Primary

  • PA0708: 1 x 7 ml GCDFP15 Bond RTU primary

  • PA0736: 1 x 7 ml Serotonin Bond RTU Primary

  • PA0752: 1 x 7 ml Macrophage Bond RTU Primary

  • PA0799: 1 x 7 ML Cytokeratin 19 Bond RTU Primary

  • PA0900: 1 x 7 ml S100 Bond RTU primary

  • PA0909: 1 x 7 ml de AE1/AE3 Bond RTU primary

  • PA0918: 1 x 7 ml Cytokeratin 20 Bond RTU primary

  • PA0942: 1 x 7 ml de Cytokeratin 7 Bond RTU primary

  • PMS2-L-CE: 1 x 1 ml de NCL-L-PMS2

  • S100P-L-CE: 1 x 1 ml NCL-L-S100p

  • TRAF-1-L-CE: 1 x 1 ml NCL-L-TRAF-1

  • VE-CAD-L-CE: 1 x 1 ml de NCL-L-VE-Cad

  • VIM-572-L-CE: 1 x 1 ml de NCL-L-VIM-572

  • VIM-V9-L-CE: 1 x 1 ml de NCL-L-VIM-V9

  • VWF-L-CE: 1 x 1 ml VWF de NCL-L-VWF

  • WT1-562-L-CE: 1 x 1 ml de NCL-L-WT1-562

Documentos Técnicos(3)

058684514920/10/2014

IVD – Retificação – Correção pela ANVISA

Publicado deferimento

042501515018/04/2016

IVD - Revalidação de registro em família

Publicado deferimento

43916910110/01/2011

IVD - Registro de produtos em família

Publicado deferimento

Petição primária

Produtos relacionados

Fonte: Dados Abertos ANVISA + API Oficial ANVISA
Última atualização: 12 de Outubro de 2026
Ver na fonte oficial da ANVISA

Faça seu cadastro grátis e consulte sem limite

Criar conta grátisJá tem conta? Entrar